Paul Celano, MD, FACP, has been named Medical Director of the Sandra & Malcolm Berman Cancer Institute at GBMC. A graduate of Mount Sinai School of Medicine in New York, New York, Dr. Celano has been a medical oncologist at GBMC since 1993 and was previously Chief of the Division of Medical Oncology in the Sandra & Malcolm Berman Cancer Institute as well as Assistant Professor of Oncology at Johns Hopkins University School of Medicine. During his tenure at GBMC, Dr. Celano has acted as the oncology representative on multiple hospital committees, assisted with developing the oncology clinical trials program, established clinical relationships with Johns Hopkins School of Medicine and served in leadership positions at the national level in numerous oncology and research organizations. Consistently recognized as a Top Doctor by Baltimore magazine, Dr. Celano is also active in legislative affairs and policy as they relate to cancer care in Maryland and the nation.
Dr. Celano succeeds Dr. Gary Cohen, who retired in January 2016 after serving as Medical Director of the Berman Cancer Institute for 25 years.
After earning her medical degree from Georgetown University and completing residency at Wills Eye Hospital and fellowship at Children's National Medical Center, Dr. Collins began her GBMC career in 1993. She is the Director of Pediatric Ophthalmology and Strabismus, the Director of Resident Education for the Ophthalmology Residency Program and has been the consulting ophthalmologist at The Maryland School for the Blind since 1993. In her new position as Chairman, Dr. Collins plans to expand and improve access to primary eye care services on GBMC's campus, support comprehensive and subspecialty ophthalmology medical staff members and advance the academic and teaching mission of the Department. She will continue her clinical practice in pediatric ophthalmology and adult strabismus.